These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 8635039)

  • 1. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Gilbert CJ; Ohly KV; Rosner G; Peters WP
    Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM; Province WS; Perrine GM; Kilgore JR
    Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Fanning J; Hilgers RD
    Obstet Gynecol; 1994 Apr; 83(4):601-4. PubMed ID: 8134073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
    Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
    Lindley C; Goodin S; McCune J; Kane M; Amamoo MA; Shord S; Pham T; Yowell S; Laliberte K; Schell M; Bernard S; Socinski MA
    Am J Clin Oncol; 2005 Jun; 28(3):270-6. PubMed ID: 15923800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
    Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, cross-over study comparing a levosulpiride-based and a metoclopramide-based combination in the prevention of ProMECE-CytaBOM-induced emesis.
    Sabbatini R; Federico M; Baldini L; Barbieri F; Maiolo MT; Silingardi V
    Haematologica; 1995; 80(5):416-20. PubMed ID: 8566881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
    Homesley HD; Hahne WF; McLees B; Heck K; Barrett RJ; Lentz SS; Woodlief L; Lovelace JV
    Am J Clin Oncol; 1993 Apr; 16(2):175-9. PubMed ID: 8452114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy.
    Olver IN; Wolf M; Laidlaw C; Bishop JF; Cooper IA; Matthews J; Smith R; Buchanan L
    Eur J Cancer; 1992; 28A(11):1798-802. PubMed ID: 1389512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
    Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
    J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
    Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy.
    Sledge GW; Einhorn L; Nagy C; House K
    Cancer; 1992 Nov; 70(10):2524-8. PubMed ID: 1423181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
    Gordon CJ; Pazdur R; Ziccarelli A; Cummings G; Al-Sarraf M
    Cancer; 1989 Feb; 63(3):578-82. PubMed ID: 2912533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
    Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
    J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
    Chevallier B; Cappelaere P; Splinter T; Fabbro M; Wendling JL; Cals L; Catimel G; Giovannini M; Khayat D; Bastit P; Claverie N
    Support Care Cancer; 1997 Jan; 5(1):22-30. PubMed ID: 9010986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.